Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Not applicableStudy completedNCT01613027
What this trial is testing

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 135
Testing effectiveness (Phase 2)Study completedNCT00617461
What this trial is testing

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Who this might be right for
Neuralgia, Postherpetic
XenoPort, Inc. 96
Not applicableNot Yet RecruitingNCT07550452
What this trial is testing

Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World Study

Who this might be right for
Atopic Dermatitis (AD)
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT02192099
What this trial is testing

Open Label Extension for GLYX13-C-202, NCT01684163

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 61
Testing effectiveness (Phase 2)Study completedNCT02202395
What this trial is testing

Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04526665
What this trial is testing

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Who this might be right for
Primary Biliary Cirrhosis
Ipsen 161
Testing effectiveness (Phase 2)Study completedNCT01500200
What this trial is testing

Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 142
Testing effectiveness (Phase 2)Study completedNCT06057064
What this trial is testing

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 116
Large-scale testing (Phase 3)Study completedNCT00883753
What this trial is testing

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 934
Large-scale testing (Phase 3)Study completedNCT00927069
What this trial is testing

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

Who this might be right for
Plaque Psoriasis
Innovaderm Research Inc. 85
Large-scale testing (Phase 3)Study completedNCT03739203
What this trial is testing

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Who this might be right for
Major Depressive Disorder
AbbVie 752
Large-scale testing (Phase 3)Study completedNCT00095147
What this trial is testing

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 431
Large-scale testing (Phase 3)Study completedNCT05455684
What this trial is testing

Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 513
Early research (Phase 1)Active Not RecruitingNCT06175338
What this trial is testing

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mabscale, LLC 208
Testing effectiveness (Phase 2)Study completedNCT01684163
What this trial is testing

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 369
Not applicableNot Yet RecruitingNCT07399158
What this trial is testing

CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 223
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05646563
What this trial is testing

Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics 12
Post-approval studies (Phase 4)Active Not RecruitingNCT05891249
What this trial is testing

Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Who this might be right for
Anemia
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Study completedNCT00901225
What this trial is testing

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkins LymphomaHodgkins Disease
Duke University 21
Post-approval studies (Phase 4)UnknownNCT01024647
What this trial is testing

Optimizing Cimzia in Crohn's Patients

Who this might be right for
Crohn's Disease
Atlanta Gastroenterology Associates 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation